We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current MNKD market cap is 1.66B. The company's latest EPS is USD -0.0433 and P/E is -139.26.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 48.61M | 51.25M | 58.47M | 66.26M | 72.39M |
Operating Income | 1.97M | 3.03M | 10.63M | 15.32M | 16.08M |
Net Income | -5.27M | 1.72M | 1.4M | 10.63M | -2.01M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 63.04M | 65.14M | 75.44M | 99.77M | 198.96M |
Operating Income | -46.51M | -38.02M | -53.48M | -68.92M | 10.59M |
Net Income | -51.9M | -57.24M | -80.93M | -87.4M | -11.94M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 313.42M | 320.33M | 475.2M | 480.88M | 443.84M |
Total Liabilities | 573.91M | 572.11M | 721.37M | 710.85M | 669.62M |
Total Equity | -260.49M | -251.78M | -246.17M | -229.97M | -225.78M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 93.73M | 108.61M | 321.16M | 295.28M | 475.2M |
Total Liabilities | 284.25M | 289.03M | 530.51M | 545.82M | 721.37M |
Total Equity | -190.53M | -180.42M | -209.35M | -250.54M | -246.17M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 3.75M | 12.42M | 34.09M | 6.7M | 10.54M |
Investing | 17.46M | 5.91M | -1.99M | -48.44M | -103.62M |
Financing | -4.79M | -5.07M | 136.61M | -3.47M | -48.02M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -88.48M | -28.13M | -61.71M | -80.68M | 34.09M |
Investing | -22.84M | 15.22M | -151.54M | 4.87M | -1.99M |
Financing | 69.86M | 49.85M | 270.27M | 21.39M | 136.61M |
Market Cap | 1.66B |
Price to Earnings Ratio | -139.26 |
Price to Sales Ratio | 8.36 |
Price to Cash Ratio | 6.97 |
Price to Book Ratio | -6.76 |
Dividend Yield | - |
Shares Outstanding | 275.78M |
Average Volume (1 week) | 2.89M |
Average Volume (1 Month) | 2.31M |
52 Week Change | 73.78% |
52 Week High | 7.62 |
52 Week Low | 3.17 |
Spread (Intraday) | 0.08 (1.32%) |
Company Name | MannKind Corporation |
Address |
2711 centerville rd wilmington, delaware 19808 |
Website | https://www.mannkindcorp.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions